.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Citi
Julphar
Teva
Medtronic
Argus Health
Boehringer Ingelheim
Cipla
Chubb
Mallinckrodt

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 200181

« Back to Dashboard

NDA 200181 describes PHENELZINE SULFATE, which is a drug marketed by Novel Labs Inc and is included in one NDA. It is available from three suppliers. Additional details are available on the PHENELZINE SULFATE profile page.

The generic ingredient in PHENELZINE SULFATE is phenelzine sulfate. There are four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the phenelzine sulfate profile page.

Summary for 200181

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details

Pharmacology for NDA: 200181

Mechanism of ActionMonoamine Oxidase Inhibitors

Medical Subject Heading (MeSH) Categories for 200181

Suppliers and Packaging for NDA: 200181

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PHENELZINE SULFATE phenelzine sulfate TABLET;ORAL 200181 ANDA Novel Laboratories, Inc. 40032-360 40032-360-21 60 TABLET in 1 BOTTLE (40032-360-21)
PHENELZINE SULFATE phenelzine sulfate TABLET;ORAL 200181 ANDA Lupin Pharmaceuticals,Inc. 43386-360 43386-360-21 60 TABLET in 1 BOTTLE (43386-360-21)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 15MG BASE
Approval Date:Dec 8, 2010TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Harvard Business School
Deloitte
Baxter
US Department of Justice
Daiichi Sankyo
Moodys
McKinsey
Dow
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot